IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $307,268 | +13.7% | 6,774 | +2.8% | 0.00% | 0.0% |
Q2 2023 | $270,347 | +11.5% | 6,589 | -2.9% | 0.00% | 0.0% |
Q1 2023 | $242,424 | +92782.8% | 6,783 | -1.6% | 0.00% | 0.0% |
Q4 2022 | $261 | -99.9% | 6,893 | +1.8% | 0.00% | 0.0% |
Q3 2022 | $300,000 | +17.6% | 6,772 | -1.8% | 0.00% | 0.0% |
Q2 2022 | $255,000 | -33.1% | 6,897 | -33.0% | 0.00% | 0.0% |
Q1 2022 | $381,000 | +10.1% | 10,293 | -9.4% | 0.00% | 0.0% |
Q4 2021 | $346,000 | +15.3% | 11,356 | +26.9% | 0.00% | 0.0% |
Q3 2021 | $300,000 | +1.7% | 8,949 | +21.0% | 0.00% | 0.0% |
Q2 2021 | $295,000 | -6.6% | 7,396 | +5.3% | 0.00% | 0.0% |
Q1 2021 | $316,000 | +28.5% | 7,027 | +68.3% | 0.00% | 0.0% |
Q2 2020 | $246,000 | -6.5% | 4,175 | -24.9% | 0.00% | 0.0% |
Q1 2020 | $263,000 | -19.6% | 5,559 | +2.7% | 0.00% | 0.0% |
Q4 2019 | $327,000 | -6.6% | 5,414 | -7.3% | 0.00% | 0.0% |
Q3 2019 | $350,000 | -6.7% | 5,841 | +0.3% | 0.00% | 0.0% |
Q2 2019 | $375,000 | +49.4% | 5,824 | +88.7% | 0.00% | 0.0% |
Q1 2019 | $251,000 | – | 3,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |